
Legislation, Medical, Anti-Inflammatory Agents, Thiazines, Ibuprofen, Arthritis, Rheumatoid, Piroxicam, Auranofin, Rheumatic Diseases, Humans, Pyrroles, Tolmetin, Anaphylaxis, Drug Labeling, Aurothioglucose, United States Food and Drug Administration, Arthritis, Palliative Care, Anti-Inflammatory Agents, Non-Steroidal, United States, Quinazolines, Drug Evaluation, Gold, Propionates, Chemical and Drug Induced Liver Injury
Legislation, Medical, Anti-Inflammatory Agents, Thiazines, Ibuprofen, Arthritis, Rheumatoid, Piroxicam, Auranofin, Rheumatic Diseases, Humans, Pyrroles, Tolmetin, Anaphylaxis, Drug Labeling, Aurothioglucose, United States Food and Drug Administration, Arthritis, Palliative Care, Anti-Inflammatory Agents, Non-Steroidal, United States, Quinazolines, Drug Evaluation, Gold, Propionates, Chemical and Drug Induced Liver Injury
| citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 57 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
